New York silver futures prices fell below $84 per ounce, with a daily drop of 6.03%. As a major trading product in the precious metals market, short-term sharp fluctuations in silver prices are usually affected by multiple factors including movements in the US dollar, market risk appetite, overall trends in commodities, and expectations regarding relevant policies. The future trend is also worth continuous attention from market participants.
New York silver futures prices fell below $84 per ounce, with a daily drop of 6.03%. As a major trading product in the precious metals market, short-term sharp fluctuations in silver prices are usually affected by multiple factors including movements in the US dollar, market risk appetite, overall trends in commodities, and expectations regarding relevant policies. The future trend is also worth continuous attention from market participants.
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
The New York silver futures price fell below the $84/ounce level, registering a daily decline of 6.03%. As an important trading product in the precious metals market, short-term sharp fluctuations in silver prices are typically influenced by multiple factors, including movements in the US dollar, market risk appetite, overall commodity trends, and expectations regarding related policies. Market participants should continue to keep a close eye on the ensuing price trends.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
London Gold and Silver Vault Data for September 2026
LBMA•2026/10/12 12:45
Bristol-Myers Squibb (BMY.US) rises in pre-market trading! Two experimental drugs report positive results in Phase 3 clinical trials, diversifying and accelerating the pipeline
Bristol Myers Squibb's two experimental drugs, used to treat a rare endocrine cancer and a deadly lung disease, have achieved success in Phase III clinical trials, injecting momentum into the pharmaceutical company’s new product pipeline.
智通财经•2026/10/12 12:36
Crypto prices
MoreBitcoin
BTC
$82,833.89
-0.30%
Ethereum
ETH
$2,534.22
+1.22%
Tether USDt
USDT
$0.9990
+0.00%
BNB
BNB
$746.6
-0.31%
XRP
XRP
$1.39
-0.16%
USDC
USDC
$0.9999
-0.00%
Solana
SOL
$110.33
+0.76%
TRON
TRX
$0.3314
+0.33%
Zcash
ZEC
$1,285.45
+4.34%
Hyperliquid
HYPE
$85.42
+0.26%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now